[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Correction
July 10, 2013

Incorrect Information in Tables

JAMA. 2013;310(2):208. doi:10.1001/jama.2013.6403

In the Original Contribution entitled “Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial” published in the May 15, 2013, issue of JAMA (2013;309[19]:2005-2015. doi:10.1001/jama.2013.4997), incorrect information was reported in 2 tables. In Table 3, the label for the last row should have appeared as “Incident lung neoplasm,” rather than “Incident lung neoplasm (MedDRA preferred term).” In Table 4, the data in the last row, “Incident lung neoplasm (MedDRA preferred term),” should have read, from left to right, 9 (1.4), 13 (1.5), 14 (2.0), 13 (1.6), 14 (1.2), 1 (5.3). This article has been corrected online.

×